1887

Abstract

Foamy viruses (FVs) are complex retroviruses which require for their replication the activity of a transcriptional trans-activator (Tas) as well as Tas-responsive elements in the viral promoters. A mutant of the chimpanzee FV strain, CFV/hu (previously called human FV), genome in which most of the U3 promoter of the CFV long terminal repeat was substituted by the constitutively active human cytomegalovirus immediate early gene enhancer/promoter was constructed. This plasmid (pTS12) and a derivative (pTS13), which has a deletion in the tas gene, gave rise to replication-competent virus. Compared with parental CFV, both mutants replicated only very poorly, with retarded growth kinetics and maximal cell-free virus titres reduced by approximately three orders of magnitude. Mutation of the DD35E motif of the CFV integrase to DA35E rendered the recombinant TS virus replication-deficient. This indicated that provirus integration is probably still required for this FV derivative, which had been converted from a complex regulated retrovirus into a simple one by incorporation of a constitutively active promoter from another virus which regularly does not integrate into the host cell genome.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-7-1591
1999-07-01
2021-09-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/7/0801591a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-7-1591&mimeType=html&fmt=ahah

References

  1. Ausubel F. M., Brent R., Kingston R. E., Moore D., Seidman J. G., Smith J. A., Struhl K. 1987 Current Protocols in Molecular Biology New York: John Wiley;
    [Google Scholar]
  2. Baum C., Ito K., Meyer J., Laker C., Ito Y., Ostertag W. 1997; The potent enhancer activity of the polycythemic strain of spleen focusforming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF. Journal of Virology 71:6323–6331
    [Google Scholar]
  3. Baunach G., Maurer B., Hahn H., Kranz M., Rethwilm A. 1993; Functional analysis of human foamy virus accessory reading frames. Journal of Virology 67:5411–5418
    [Google Scholar]
  4. Boris-Lawrie K., Temin H. M. 1995; Genetically simpler bovine leukemia virus derivatives can replicate independently of tax and rex. Journal of Virology 69:1920–1924
    [Google Scholar]
  5. Boris-Lawrie K., Altarenova V., Altaner C., Kucerova L., Temin H. M. 1997; In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex. Journal of Virology 71:1514–1520
    [Google Scholar]
  6. Boshart M., Weber F., Jahn G., Dorsch-Hasler K., Fleckenstein B., Schaffner W. 1985; A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521–530
    [Google Scholar]
  7. Brown P. O. 1997; Integration. In Retroviruses pp 161–203 Edited by Coffin J. M. Hughes S. H., Varmus H. E. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press;
    [Google Scholar]
  8. Cullen B. R. 1991; Human immunodeficiency virus as a prototypic complex retrovirus. Journal of Virology 65:1053–1056
    [Google Scholar]
  9. DuBridge R. B., Tang P., Hsia H. C., Leong P.-M., Miller J. H., Calos M. P. 1987; Analysis of mutation in human cells by using Epstein–Barr virus shuttle system. Molecular and Cellular Biology 7:379–387
    [Google Scholar]
  10. Enssle J., Moebes A., Heinkelein M., Panhuysen M., Mauer B., Schweizer M., Neumann-Haefelin D., Rethwilm A. 1999; An active human foamy virus integrase is required for virus replication. Journal of General Virology 80:1445–1452
    [Google Scholar]
  11. Erlwein O., Rethwilm A. 1993; BEL-1 transactivator responsive sequences in the long terminal repeat of human foamy virus. Virology 196:256–268
    [Google Scholar]
  12. Hahn H., Baunach G., Bräutigam S., Mergia A., Neumann-Haefelin D., Daniel M. D., McClure M. O., Rethwilm A. 1994; Reactivity of primate sera to foamy virus Gag and Bet proteins. Journal of General Virology 75:2635–2644
    [Google Scholar]
  13. He F., Blair W. S., Fukushima J., Cullen B. R. 1996; The human foamy virus bel-1 transcriptional factor is a sequence-specific DNA binding protein. Journal of Virology 70:3902–3908
    [Google Scholar]
  14. Heinkelein M., Schmidt M., Fischer N., Moebes A., Lindemann D., Enssle J., Rethwilm A. 1998; Characterization of a cis-acting sequence in the pol region required to transfer human foamy virus vectors. Journal of Virology 72:6307–6314
    [Google Scholar]
  15. Hornung M., Lindemann D., Kraus C., Peters A., Berberich I. 1998; The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IgM-induced growth arrest. European Journal of Immunology 28:3812–3823
    [Google Scholar]
  16. Keller A., Partin K. M., Löchelt M., Bannert H., Flügel R. M., Cullen B.R. 1991; Characterization of the transcriptional trans activator of human foamy retrovirus. Journal of Virology 65:2589–2594
    [Google Scholar]
  17. Kögel D., Aboud M., Flugel R. M. 1995; Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains. Virology 213:97–108
    [Google Scholar]
  18. Lee K. I., Lee A. H., Sung Y. C. 1993; Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus. Journal of Virology 67:2317–2326
    [Google Scholar]
  19. Lindemann D., Rethwilm A. 1998; Characterization of a human foamy virus 170 kD env–bet fusion protein generated by alternative splicing. Journal of Virology 72:4088–4094
    [Google Scholar]
  20. Linial M. L. 1999; Foamy viruses are nonconventional retroviruses. Journal of Virology 73:1747–1755
    [Google Scholar]
  21. Löchelt M., Muranyi W., Flugel R. M. 1993; Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proceedings of the National Academy of Sciences, USA 90:7317–7321
    [Google Scholar]
  22. Löchelt M., Flugel R. M., Aboud M. 1994; The human foamy virus internal promoter directs the expression of the functional bel 1 transactivator and bet protein early after infection. Journal of Virology 68:638–645
    [Google Scholar]
  23. Löchelt M., Yu S., Linial M., Flugel R. M. 1995; The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology 206:601–610
    [Google Scholar]
  24. Mocarski E. S. 1996; Cytomegaloviruses and their replication. In Fields Virology 3rd edn, pp 2447–2492 Edited by Fields B. N. Knipe D. M., Howley P. M. New York: Lippincott-Raven;
    [Google Scholar]
  25. Moebes A., Enssle J., Bieniasz P. D., Heinkelein M., Lindemann D., Bock M., McClure M. O., Rethwilm A. 1997; Human foamy virus reverse transcription that occurs late in the viral replication cycle. Journal of Virology 71:7305–7311
    [Google Scholar]
  26. Namba M., Nishitani K., Hyodoh F., Fukushima F., Kimoto T. 1985; Neoplastic transformation of human diploid fibroblasts (KMST-6) by treatment with 60Co gamma rays. International Journal of Cancer 35:275–280
    [Google Scholar]
  27. Pietschmann T., Heinkelein M., Zentgraf H., Rethwilm A., Lindemann D. 1999; Foamy virus capsids require the cognate envelope protein for particle export. Journal of Virology 73:2613–2621
    [Google Scholar]
  28. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  29. Rethwilm A. 1995; Regulation offoamy virus gene expression. Current Topics in Microbiology and Immunology 193:1–23
    [Google Scholar]
  30. Rethwilm A. 1996; Unexpected replication pathways offoamy viruses. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 13: (Suppl 1) S248–S253
    [Google Scholar]
  31. Rethwilm A., Mori K., Maurer B., ter Meulen V. 1990; Transacting transcriptional activation of human spumaretrovirus LTR in infected cells. Virology 175:568–571
    [Google Scholar]
  32. Rethwilm A., Erlwein O., Baunach G., Maurer B., ter Meulen V. 1991; The transcriptional transactivator of human foamy virus maps to the bel1 genomic region. Proceedings of the National Academy of Sciences, USA 88:941–945
    [Google Scholar]
  33. Schliephake A. W., Rethwilm A. 1994; Nuclear localization of foamy virus gag precursor protein. Journal of Virology 68:4946–4954
    [Google Scholar]
  34. Schmidt M., Rethwilm A. 1995; Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 210:167–178
    [Google Scholar]
  35. Schmidt M., Herchenröder O., Heeney J., Rethwilm A. 1997; Long terminal repeat U3 length polymorphism of human foamy virus. Virology 230:167–178
    [Google Scholar]
  36. Temin H. M. 1993; A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 90:4419–4420
    [Google Scholar]
  37. Venkatesh L. K., Chinnadurai G. 1993; The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function. Journal of Virology 67:3868–3876
    [Google Scholar]
  38. Weiss R. A. 1996; Foamy viruses bubble on. Nature 380:201
    [Google Scholar]
  39. Yu S. F., Linial M. L. 1993; Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. Journal of Virology 67:6618–6624
    [Google Scholar]
  40. Yu S. F., Baldwin D. N., Gwynn S. R., Yendapalli S., Linial M. L. 1996; Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271:1579–1582
    [Google Scholar]
  41. Yu S. F., Sullivan M. D., Linial M. L. 1999; Evidence that the human foamy virus genome is DNA. Journal of Virology 73:1565–1572
    [Google Scholar]
  42. Zou J. X., Luciw P. A. 1996; The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter. Proceedings of the National Academy of Sciences, USA 93326–330
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-7-1591
Loading
/content/journal/jgv/10.1099/0022-1317-80-7-1591
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error